Biosimilars and the long game

Huzair, Farah and Kale, Dinar (2015). Biosimilars and the long game. Trends in Biotechnology, 33(5) pp. 250–252.

DOI: https://doi.org/10.1016/j.tibtech.2015.01.001

URL: http://www.sciencedirect.com/science/article/pii/S...

Abstract

Despite greater certainty for biosimilar markets and regulation, the change that was seen in the small-molecule pharmaceuticals market with the rapid entrance of emerging-country generics suppliers will not be replicated exactly. The long game has yet to be played out, and recent changes in regulation, science, and production technology are likely to impact on future patterns of partnership and production.

Viewing alternatives

Metrics

Item Actions

Export

You can export this page using these formats Digital Object Identifier - DOI